HKEX: 2877 - China Shineway Pharmaceutical Group Limited

Yield per half year: +0.5896%
Dividend yield: +8.34%
Sector: Healthcare

Share chart China Shineway Pharmaceutical Group Limited


About China Shineway Pharmaceutical Group Limited

China Shineway Pharmaceutical Group Limited, инвестиционная холдинговая компания, занимается исследованиями и разработками, производством и продажей китайских лекарств в Китайской Народной Республике и Гонконге. Компания предлагает китайские лекарства в форме мягких капсул, гранул и инъекций, а также гранулы формулы ТКМ в различных терапевтических областях, включая заболевания органов дыхания, пищеварения, сердечно-сосудистые и цереброваскулярные заболевания, ортопедию, педиатрию, нервную систему и др. области, а также лекарства для укрепления организма.

more details
Он также занимается торговлей сельскохозяйственной продукцией. Компания была зарегистрирована в 2002 году и имеет штаб-квартиру в Шицзячжуане, Китайская Народная Республика. China Shineway Pharmaceutical Group Limited является дочерней компанией Forway Investment Limited.
Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 2004-12-02
ISIN KYG2110P1000
Industry Pharmaceuticals
Sector Health Care
Валюта hkd
Валюта отчета cny
Див.доход ао 6.62
Дивиденд ао 0.581
Сайт https://www.shineway.com
Цена ао 8.53
Change price per day: +1.67% (8.39)
Change price per week: -0.1171% (8.54)
Change price per month: +3.02% (8.28)
Change price per 3 month: -13.4% (9.85)
Change price per half year: +0.5896% (8.48)
Change price per year: -1.95% (8.7)
Change price per 3 year: +33.28% (6.4)
Change price per 5 year: +15.27% (7.4)
Change price per 10 year: 0% (8.53)
Change price per year to date: -8.87% (9.36)
All parameters

Underestimation

Title Value Grade
P/S 1.13 9
P/BV 0.7249 10
P/E 5.26 10
EV/EBITDA 0.6 10
Total: 9.75

Efficiency

Title Value Grade
ROA, % 10.89 4
ROE, % 14.45 4
Total: 3.67

Dividends

Title Value Grade
Div yield, % 8.34 10
DSI 0.8571 8.57
Total: 8.24

Debt

Title Value Grade
Debt/EBITDA 0.0067 10
Total: 10

Growth impulse

Title Value Grade
Yield Revenue, % 66.91 8
Yield Ebitda, % 109.23 10
Yield EPS, % 110.95 10
Total: 9.4
More

Institutions Volume Share, %
iShares Core MSCI Emerging Markets ETF 4636000 0.56
Vanguard International Stock Index-Emerging Markets Stk 4122885 0.5
Vanguard International Stock Index-Total Intl Stock Indx 3751854 0.45
DFA Emerging Markets Core Equity Portfolio 2580000 0.31
DFA Investment Dimensions-DFA Emerging Mkts Value 1750000 0.21
iShares Core MSCI Total International Stock ETF 1084000 0.13
DFA Emerging Markets Small Cap Series 1052200 0.13
College Retirement Equities Fund-Stock Account 984000 0.12
Vanguard Intl Equity Index Fds-FTSE All World ex U.S.Small Cap Index 972343 0.12
TIAA-CREF Funds-Quant International Small Cap Equity Fund 649000 0.08

ETF Share, % Profitability for 1 year, % Dividends, %
FlexShares Morningstar Emerging Markets Factor Tilt Index Fund 0.03698 12.46 3.59676
SPDR S&P China ETF 0.03437 17.02 3.40103
SPDR S&P Emerging Markets Small Cap ETF 0.02568 5.46 3.03583
Avantis Emerging Markets Value ETF 0.01914 14.12 4.22231
Avantis Responsible Emerging Markets Equity ETF 0.01339 17.6 3.1719
Vanguard FTSE All-World ex-US Small-Cap ETF 0.01 9.39 3.09932
Avantis Emerging Markets Equity ETF 0.00662 8.77 3.60513
Vanguard ESG International Stock ETF 0 6.39 3.07501



Head Job title Payment Year of birth
Mr. Zhenjiang Li Co-Founder & Executive Chairman 4.83M 1955 (70 years)
Ms. Yunxia Xin Co-Founder & Executive Director 3.37M 1963 (62 years)
Mr. Huimin Li Executive Director 2.26M 1968 (57 years)
Mr. Bun Ching Lee Financial Controller & Company Secretary N/A 1973 (52 years)
Mr. Yudong Zhang General Manager of Sales & Marketing N/A 1974 (51 year)
Mr. King Kuen Hung AICPA, HKICPA, MBA Director of Investor Relation 1966 (59 years)

Address: China, Shijiazhuang, No. 168 Shiluan Street - open in Google maps, open in Yandex maps
Website: https://www.shineway.com